Jane F. Barlow

Insider Reports History

Location
Boca Raton, FL
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane F. Barlow:

Form 4 holding Director

Viracta Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
50,000
Estimated value
Report date
20 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CONTRAFECT Corp

Security class
Options (Right to Buy)
Shares / value
42,000
Estimated value
Report date
17 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jane F. Barlow

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .